Drug Shortage Report for BOOSTRIX-POLIO

Last updated on 2017-12-07
Report ID 19888
Drug Identification Number 02312557
Brand name BOOSTRIX-POLIO
Common or Proper name Combined diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) INACTIVATED POLIOVIRUS TYPE I INACTIVATED POLIOVIRUS TYPE II INACTIVATED POLIOVIRUS TYPE III TETANUS TOXOID ADSORBED DIPHTHERIA TOXOID ADSORBED PERTUSSIS TOXOID ADSORBED FILAMENTOUS HAEMAGGLUTININ ADSORBED PERTACTIN ADSORBED
Strength(s) 40D 8D 32D 5.0LF 2.5LF 8MCG 8MCG 2.5MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 10's
ATC code J07CA
ATC description BACTERIAL AND VIRAL VACCINES, COMBINED
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-11-08
Estimated end date 2017-12-07
Actual end date 2017-12-06
Shortage status Resolved
Updated date 2017-12-07
Company comments Supply released November 10, 2017 with limited quantity.
Health Canada comments
Company contact information 1-800-387-7374